I17 Reduced rates of juvenile onset recurrent respiratory papillomatosis in australia after implementation of a national hpv vaccination program. (12th March 2018)

• Record Type: Journal Article
• Authors: Zurynski, Y; Brotherton, JML; Novakovic, D; Cheng, ATL; Booy, R; Berkowitz, R; Garland, SM; Elliott, E; Black, R
• Is Part Of: Archives of disease in childhood. Volume 103(2018)Supplement 1
• Page Start: A203
• Page End: A203
• Publication Date: 2018-03-12
• Subjects: Children -- Diseases -- Periodicals; Infants -- Diseases -- Periodicals; 618.920005
• DOI: 10.1136/archdischild-2018-rcpch.485
• Languages: English
• ISSNs: 0003-9888

Abstract

Abstract : Aims: Juvenile onset Recurrent Respiratory Papillomatosis (JoRRP) is a rare chronic disease caused by human papillomavirus (HPV) types 6 and 11. Children with RRP require multiple surgical interventions; tracheostomy may be needed and sometimes the disease is fatal. Infections are now preventable through HPV vaccination. Following an extensive quadrivalent HPV vaccine catch-up program for females aged 12–26 years in 2007–2009, in Australia, we aimed to monitor the changes in incidence and demographics of JoRRP over time. Methods: The Australian Paediatric Surveillance Unit (APSU) conducted national surveillance for JRRoP using its well established reporting system. In addition to the ~1450 paediatricians who report to the APSU each month, paediatric otorhinolaryngologists were also enrolled in the APSU and offered HPV typing. We report findings for the five-year period to end 2016. Results: The average annual incidence rate was 0.0715 per 1 00 000 children aged <16 years. The largest number of cases was reported in the first year, with decreasing annual frequency thereafter. The rate declined significantly from 0.163 per 1 00 000 in 2012 to 0.024 per 1 00 000 in 2016 (p=0.034). Among the 15 incident cases 60% male, 60% were first born children and 13 (87%) were born vaginally. None of the mothers of these children had received the HPV vaccine before pregnancy, and 3 (20%) of the mothers had a history of genital warts. Seven genotyped cases were positive for HPV including 4 that were HPV6 positive and 3 that were HPV11 positive. Conclusion: To our knowledge this is the first report internationally documenting decline in JoRRP incidence in children following a quadrivalent HPV vaccination program.